Woodstock Corp Sells 17,545 Shares of CVS Health Co. (NYSE:CVS)

Woodstock Corp lowered its holdings in CVS Health Co. (NYSE:CVSFree Report) by 28.5% during the third quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 44,073 shares of the pharmacy operator’s stock after selling 17,545 shares during the quarter. Woodstock Corp’s holdings in CVS Health were worth $2,771,000 as of its most recent filing with the SEC.

Several other large investors also recently made changes to their positions in CVS. V Square Quantitative Management LLC boosted its holdings in CVS Health by 145.7% in the fourth quarter. V Square Quantitative Management LLC now owns 7,456 shares of the pharmacy operator’s stock valued at $589,000 after acquiring an additional 4,421 shares during the last quarter. Centaurus Financial Inc. raised its stake in shares of CVS Health by 2.0% during the fourth quarter. Centaurus Financial Inc. now owns 15,390 shares of the pharmacy operator’s stock worth $1,215,000 after buying an additional 301 shares during the last quarter. Syon Capital LLC lifted its holdings in CVS Health by 43.7% in the fourth quarter. Syon Capital LLC now owns 10,720 shares of the pharmacy operator’s stock valued at $846,000 after buying an additional 3,262 shares during the period. Scarborough Advisors LLC bought a new position in CVS Health in the fourth quarter valued at approximately $37,000. Finally, Creekmur Asset Management LLC acquired a new stake in CVS Health during the 4th quarter worth $34,000. Institutional investors own 80.66% of the company’s stock.

CVS Health Stock Down 0.3 %

NYSE CVS opened at $66.63 on Monday. The business has a fifty day moving average price of $59.12 and a two-hundred day moving average price of $60.89. The stock has a market capitalization of $83.65 billion, a PE ratio of 11.71, a PEG ratio of 0.93 and a beta of 0.54. CVS Health Co. has a fifty-two week low of $52.77 and a fifty-two week high of $83.25. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.86 and a quick ratio of 0.66.

CVS Health (NYSE:CVSGet Free Report) last issued its earnings results on Wednesday, August 7th. The pharmacy operator reported $1.83 EPS for the quarter, topping the consensus estimate of $1.73 by $0.10. The firm had revenue of $91.23 billion during the quarter, compared to the consensus estimate of $91.41 billion. CVS Health had a return on equity of 12.72% and a net margin of 1.98%. The business’s quarterly revenue was up 2.6% on a year-over-year basis. During the same quarter in the previous year, the firm earned $2.21 earnings per share. Equities analysts expect that CVS Health Co. will post 6.51 earnings per share for the current fiscal year.

CVS Health Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 1st. Investors of record on Monday, October 21st will be paid a $0.665 dividend. The ex-dividend date is Monday, October 21st. This represents a $2.66 annualized dividend and a dividend yield of 3.99%. CVS Health’s dividend payout ratio is 46.75%.

Wall Street Analysts Forecast Growth

Several research firms have weighed in on CVS. Royal Bank of Canada reiterated an “outperform” rating and issued a $68.00 target price on shares of CVS Health in a report on Wednesday, September 4th. Truist Financial boosted their price objective on CVS Health from $66.00 to $76.00 and gave the company a “buy” rating in a research report on Friday. Wells Fargo & Company raised their target price on shares of CVS Health from $60.00 to $61.00 and gave the stock an “equal weight” rating in a report on Monday, August 12th. Deutsche Bank Aktiengesellschaft lowered their price objective on shares of CVS Health from $64.00 to $63.00 and set a “hold” rating for the company in a research report on Friday, August 9th. Finally, Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $62.00 target price on shares of CVS Health in a research note on Tuesday, October 1st. Nine investment analysts have rated the stock with a hold rating and thirteen have issued a buy rating to the stock. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average price target of $75.26.

View Our Latest Report on CVS Health

CVS Health Profile

(Free Report)

CVS Health Corporation provides health solutions in the United States. It operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services.

Recommended Stories

Institutional Ownership by Quarter for CVS Health (NYSE:CVS)

Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.